Guardant Health
Guardant Health, Bayshore HealthCare Partner to Provide Testing in Canadian Clinics
Providers working in Bayshore's clinics will offer Guardant's therapy selection, residual disease detection, and screening tests to their patients.
Guardant Shield CRC Screening Test Covered by VA Community Care Program
Eligible veterans will be able to access the test with no copay through community-based providers, where VA services are unavailable.
A discussion at the Precision Medicine Tri-Con demonstrated that stakeholders are narrowing in on the challenges to realizing the promise of solid tumor MRD.
Legislation is needed to improve pharmacogenetic and pharmacogenomic testing access and education, and to align reimbursement with guidelines, said experts at the Precision Med Tri-Con.
Guardant Health's Shield Colorectal Cancer Blood Test Garners CMS Advanced Diagnostic Status
The test will be reimbursed at the price of $1,495 for Medicare patients during the initial nine-month ADLT period starting on April 1.